Literature DB >> 9093780

Blood cortisol and dehydroepiandrosterone sulphate (DHEAS) levels and CD4 T cell counts in HIV infection.

B de la Torre1, G von Krogh, M Svensson, V Holmberg.   

Abstract

OBJECTIVE: Blood cortisol and dehydroepiandrosterone sulphate (DHEAS) levels, and CD4 T cell counts were assessed in a group of 44 patients with HIV infection (17 asymptomatic and 27 symptomatic). The steroid levels were compared to those in 80 healthy subjects.
RESULTS: The mean cortisol level did not differ between the HIV patients and controls. However, a broad variability existed among the patients; thus, asymptomatic HIV patients revealed a significantly higher mean level than the controls (348 nmol/l vs. 280 nmol/l; p < 0.01). Furthermore, 20 patients had levels above, 16 within, and 8 below the confidence limits of the cortisol levels in controls. This variability might reflect differences in adrenocortical responses to psychological stress and adaptive reactions among patients with HIV infection. The mean DHEAS was markedly lowered in the patient group (1450 nmol/l in patients vs. 3300 nmol/l in controls; p < 0.001). A decrease below the confidence limits of the controls existed in 41 (93%) of the 44 patients. A significant correlation was also found between the low DHEAS levels and low CD4 T cell counts in the patients (p < 0.01), while no such correlation existed for cortisol.
CONCLUSION: Whether low DHEAS levels might contribute to some of the pathophysiologic features and/or symptoms seen in HIV infection needs to be investigated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9093780

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

1.  Assessment of DHEAS, cortisol, and DHEAS/cortisol ratio in patients with COVID-19: a pilot study.

Authors:  Sojit Tomo; Mithu Banerjee; Sreenivasulu Karli; Purvi Purohit; Prasenjit Mitra; Praveen Sharma; M K Garg; Bharat Kumar
Journal:  Hormones (Athens)       Date:  2022-07-08       Impact factor: 3.419

2.  Metabolic and hormonal effects of oral DHEA in premenopausal women with HIV infection: a randomized, prospective, placebo-controlled pilot study.

Authors:  L Poretsky; L Song; D J Brillon; S Ferrando; J Chiu; M McElhiney; A Ferenczi; C Sison; I Haller; J Rabkin
Journal:  Horm Metab Res       Date:  2008-09-22       Impact factor: 2.936

3.  Relation of morning serum cortisol to prothrombotic activity in women with stable coronary artery disease.

Authors:  Roland von Känel; Brent T Mausbach; Brigitte M Kudielka; Kristina Orth-Gomér
Journal:  J Thromb Thrombolysis       Date:  2007-06-12       Impact factor: 2.300

4.  Role of serum dehydroepiandrosterone sulfate level on the clearance of chronic hepatitis B virus infection.

Authors:  Jia-Feng Wu; Wen-Yu Tsai; Yi-Ching Tung; Huey-Ling Chen; Yen-Hsuan Ni; Hong-Yuan Hsu; Mei-Hwei Chang
Journal:  J Gastroenterol       Date:  2013-06-01       Impact factor: 7.527

Review 5.  Natural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impacts.

Authors:  Jia-Feng Wu; Mei-Hwei Chang
Journal:  J Biomed Sci       Date:  2015-10-20       Impact factor: 8.410

6.  The relationship of hair glucocorticoid levels to immunological and virological outcomes in a large cohort of combination antiretroviral therapy treated people living with HIV.

Authors:  Quan Zhang; Shuaifeng Liu; Xiaoming Li; Shan Qiao; Yuejiao Zhou; Zhiyong Shen
Journal:  BMC Infect Dis       Date:  2022-03-20       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.